학술논문
Proactive treatment of angiotensin receptor antibodies in kidney transplantation with plasma exchange and/or candesartan is safe and associated with excellent graft survival at 4 years: A single centre Australian experience
Document Type
Article
Author
Source
In Human Immunology August 2019 80(8):573-578
Subject
Language
ISSN
0198-8859